Ticker
ATYRCompany Name
ATYR PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 101.53M | $ 20.1M | 19.79% |
3/31/2025 | $ 97.25M | $ 12.79M | 13.16% |
12/31/2024 | $ 96.83M | $ 14.01M | 14.46% |
9/30/2024 | $ 91.62M | $ 14.38M | 15.7% |
6/30/2024 | $ 105.94M | $ 9.7M | 9.16% |
3/31/2024 | $ 113.25M | $ 10.02M | 8.85% |
12/31/2023 | $ 120.65M | $ 26.03M | 21.57% |
9/30/2023 | $ 125.07M | $ 13.24M | 10.58% |
6/30/2023 | $ 132.75M | $ 15.73M | 11.85% |
3/31/2023 | $ 136.84M | $ 23.88M | 17.45% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ATYR PHARMA INC is calculated as follows: CashnEq [ $ 18.15M ] / Assets [ $ 41.64M ]
(=) Cash to Assets [ 43.59% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |